Hologic Inc. (HOLX) Tops Q2 EPS by 2c; Guides Q3
Tweet
Share
E-mailGet Alerts HOLX Hot Sheet
Price: $76.01 --0%
Financial Fact:
Income before income taxes: 107.6M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Income before income taxes: 107.6M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Hologic Inc. (NASDAQ: HOLX) reported Q2 EPS of $0.30, $0.02 better than the analyst estimate of $0.28. Revenue for the quarter came in at $438.7 million versus the consensus estimate of $433.21 million.
Sees Q3 2011 EPS of $0.31-$0.32, versus the consensus of $0.32. Also sees Q3 2011 revenue of $443-$448 million, versus the consensus of $443.9 million.
Sees Q3 2011 EPS of $0.31-$0.32, versus the consensus of $0.32. Also sees Q3 2011 revenue of $443-$448 million, versus the consensus of $443.9 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
